$660 Million is the total value of Soleus Capital Management, L.P.'s 65 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 69.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | New | SPDR SER TRput | $397,704,000 | – | 2,825,000 | +100.0% | 52.48% | – |
| BCAB | New | BIOATLA INC | $108,130,000 | – | 3,179,362 | +100.0% | 14.27% | – |
| EPIX | Buy | ESSA PHARMA INC | $28,342,000 | +124.8% | 2,375,681 | +30.0% | 3.74% | -44.0% |
| GLTO | New | GALECTO INC | $18,923,000 | – | 1,512,648 | +100.0% | 2.50% | – |
| ISEE | Sell | IVERIC BIO INC | $11,037,000 | +16.1% | 1,597,279 | -5.3% | 1.46% | -71.1% |
| NVTA | New | INVITAE CORP | $10,233,000 | – | 244,760 | +100.0% | 1.35% | – |
| LNTH | Buy | LANTHEUS HLDGS INC | $10,011,000 | +55.1% | 742,085 | +45.6% | 1.32% | -61.4% |
| CCCC | New | C4 THERAPEUTICS INC | $8,897,000 | – | 268,548 | +100.0% | 1.17% | – |
| New | IONIS PHARMACEUTICALS INCnote 0.125%12/1 | $8,675,000 | – | 8,500,000 | +100.0% | 1.14% | – | |
| XENE | Buy | XENON PHARMACEUTICALS INC | $8,584,000 | +55.0% | 558,117 | +11.6% | 1.13% | -61.4% |
| EXEL | New | EXELIXIS INC | $7,844,000 | – | 390,847 | +100.0% | 1.04% | – |
| NTRA | Sell | NATERA INC | $7,383,000 | +1.1% | 74,189 | -26.6% | 0.97% | -74.8% |
| VCEL | Sell | VERICEL CORP | $7,305,000 | +11.7% | 236,589 | -33.0% | 0.96% | -72.2% |
| INBX | Sell | INHIBRX INC | $7,049,000 | -3.7% | 213,807 | -47.4% | 0.93% | -76.0% |
| IRMD | Buy | IRADIMED CORP | $6,931,000 | +63.1% | 303,998 | +53.0% | 0.92% | -59.4% |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $6,182,000 | +7.9% | 199,867 | -29.1% | 0.82% | -73.1% |
| New | DARIOHEALTH CORP | $5,739,000 | – | 401,606 | +100.0% | 0.76% | – | |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $5,504,000 | -24.8% | 206,844 | -47.4% | 0.73% | -81.3% |
| LYRA | Buy | LYRA THERAPEUTICS INC | $5,199,000 | +320.3% | 456,138 | +312.2% | 0.69% | +4.6% |
| SBTX | New | SILVERBACK THERAPEUTICS INC | $4,997,000 | – | 107,826 | +100.0% | 0.66% | – |
| VSPR | New | VESPER HEALTHCARE ACQSTN COR | $4,711,000 | – | 416,551 | +100.0% | 0.62% | – |
| NVCR | Sell | NOVOCURE LTD | $4,326,000 | -25.8% | 24,999 | -52.3% | 0.57% | -81.5% |
| OAC | New | OAKTREE ACQUISITION CORP | $4,111,000 | – | 281,565 | +100.0% | 0.54% | – |
| SRDX | Buy | SURMODICS INC | $4,046,000 | +34.6% | 92,975 | +20.3% | 0.53% | -66.5% |
| MSON | Buy | MISONIX INC | $3,767,000 | +28.3% | 301,333 | +20.4% | 0.50% | -68.1% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $3,214,000 | +537.7% | 64,284 | +598.5% | 0.42% | +58.8% |
| DXCM | Buy | DEXCOM INC | $3,018,000 | -3.5% | 8,165 | +7.7% | 0.40% | -76.0% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $2,959,000 | -14.0% | 18,938 | -37.0% | 0.39% | -78.6% |
| ITMR | ITAMAR MED LTDsponsored ads | $2,791,000 | -2.8% | 140,524 | 0.0% | 0.37% | -75.8% | |
| ESTA | New | ESTABLISHMENT LABS HLDGS INC | $2,519,000 | – | 66,921 | +100.0% | 0.33% | – |
| Buy | GOSSAMER BIO INCnote 5.000% 6/0 | $2,477,000 | +142.6% | 2,750,000 | +175.0% | 0.33% | -39.6% | |
| NEO | New | NEOGENOMICS INC | $2,474,000 | – | 45,951 | +100.0% | 0.33% | – |
| RFL | RAFAEL HLDGS INC | $2,442,000 | +50.5% | 104,737 | 0.0% | 0.32% | -62.6% | |
| MRK | Buy | MERCK & CO. INC | $2,324,000 | +5.4% | 28,406 | +6.9% | 0.31% | -73.7% |
| TPTX | New | TURNING POINT THERAPEUTICS I | $2,317,000 | – | 19,013 | +100.0% | 0.31% | – |
| ABBV | New | ABBVIE INC | $2,301,000 | – | 21,477 | +100.0% | 0.30% | – |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $2,282,000 | -40.7% | 185,719 | -60.7% | 0.30% | -85.2% |
| CMPS | Sell | COMPASS PATHWAYS PLCsponsored ads | $2,036,000 | -62.8% | 42,743 | -72.8% | 0.27% | -90.7% |
| ONCR | New | ONCORUS INC | $1,824,000 | – | 56,422 | +100.0% | 0.24% | – |
| PRVB | Sell | PROVENTION BIO INC | $1,795,000 | +0.3% | 105,941 | -24.0% | 0.24% | -75.0% |
| MRTX | New | MIRATI THERAPEUTICS INC | $1,722,000 | – | 7,838 | +100.0% | 0.23% | – |
| OSH | Sell | OAK STR HEALTH INC | $1,689,000 | -46.3% | 27,612 | -53.1% | 0.22% | -86.6% |
| CRSP | Buy | CRISPR THERAPEUTICS AGnamen akt | $1,657,000 | +94.3% | 10,825 | +6.1% | 0.22% | -51.5% |
| NVRO | Sell | NEVRO CORP | $1,660,000 | -0.1% | 9,589 | -19.6% | 0.22% | -75.1% |
| Sell | TRILLIUM THERAPEUTICS INC | $1,527,000 | -4.7% | 103,819 | -7.9% | 0.20% | -76.3% | |
| ADVM | Sell | ADVERUM BIOTECHNOLOGIES INC | $1,474,000 | -60.7% | 135,992 | -62.7% | 0.19% | -90.2% |
| KDMN | Buy | KADMON HLDGS INC | $1,396,000 | +77.4% | 336,442 | +67.5% | 0.18% | -55.9% |
| MGEN | New | MIRAGEN THERAPEUTICS INC | $1,335,000 | – | 81,185 | +100.0% | 0.18% | – |
| PIRS | PIERIS PHARMACEUTICALS INC | $1,250,000 | +20.8% | 500,000 | 0.0% | 0.16% | -69.9% | |
| SRRK | New | SCHOLAR ROCK HLDG CORP | $1,188,000 | – | 24,484 | +100.0% | 0.16% | – |
| ZYME | Sell | ZYMEWORKS INC | $1,070,000 | -74.3% | 22,631 | -74.6% | 0.14% | -93.6% |
| CRDF | Sell | CARDIFF ONCOLOGY INC | $1,024,000 | -74.4% | 56,909 | -79.8% | 0.14% | -93.6% |
| BIIB | Sell | BIOGEN INC | $955,000 | -70.9% | 3,899 | -66.3% | 0.13% | -92.8% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $926,000 | -77.2% | 12,655 | -75.8% | 0.12% | -94.3% |
| RVNC | Sell | REVANCE THERAPEUTICS INC | $882,000 | -15.7% | 31,136 | -25.2% | 0.12% | -79.1% |
| MDNA | Sell | MEDICENNA THERAPEUTICS CORP | $874,000 | -15.1% | 186,799 | -24.9% | 0.12% | -78.9% |
| KYMR | Sell | KYMERA THERAPEUTICS INC | $813,000 | +64.2% | 13,116 | -14.3% | 0.11% | -59.2% |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $657,000 | – | 7,661 | +100.0% | 0.09% | – |
| KRYS | New | KRYSTAL BIOTECH INC | $625,000 | – | 10,423 | +100.0% | 0.08% | – |
| FATE | Sell | FATE THERAPEUTICS INC | $621,000 | +60.1% | 6,830 | -29.7% | 0.08% | -60.2% |
| AXGN | Sell | AXOGEN INC | $605,000 | -61.5% | 33,813 | -75.0% | 0.08% | -90.4% |
| ALPN | New | ALPINE IMMUNE SCIENCES INC | $517,000 | – | 41,064 | +100.0% | 0.07% | – |
| TARA | Sell | PROTARA THERAPEUTICS INC | $390,000 | -76.8% | 16,093 | -83.9% | 0.05% | -94.3% |
| OACWS | New | OAKTREE ACQUISITION CORP*w exp 99/99/999 | $358,000 | – | 91,793 | +100.0% | 0.05% | – |
| STAA | Sell | STAAR SURGICAL CO | $261,000 | -69.9% | 3,300 | -78.5% | 0.03% | -92.6% |
| UMRX | Exit | UNUM THERAPEUTICS INC | $0 | – | -47,900 | -100.0% | -0.06% | – |
| Exit | INSMED INCnote 1.750% 1/1 | $0 | – | -180,000 | -100.0% | -0.10% | – | |
| CNST | Exit | CONSTELLATION PHARMCETICLS I | $0 | – | -10,742 | -100.0% | -0.12% | – |
| AFMD | Exit | AFFIMED N V | $0 | – | -68,493 | -100.0% | -0.12% | – |
| IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -1,187 | -100.0% | -0.15% | – |
| CSTL | Exit | CASTLE BIOSCIENCES INC | $0 | – | -6,269 | -100.0% | -0.17% | – |
| ENTA | Exit | ENANTA PHARMACEUTICALS INC | $0 | – | -11,500 | -100.0% | -0.28% | – |
| PCRX | Exit | PACIRA BIOSCIENCES | $0 | – | -10,200 | -100.0% | -0.32% | – |
| HARP | Exit | HARPOON THERAPEUTICS INC | $0 | – | -42,472 | -100.0% | -0.38% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -167,798 | -100.0% | -0.38% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -10,977 | -100.0% | -0.44% | – |
| PODD | Exit | INSULET CORP | $0 | – | -3,632 | -100.0% | -0.46% | – |
| IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -19,648 | -100.0% | -0.49% | – |
| LRMR | Exit | LARIMAR THERAPEUTICS INC | $0 | – | -76,184 | -100.0% | -0.61% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -20,454 | -100.0% | -1.00% | – |
| ZYXI | Exit | ZYNEX INC | $0 | – | -118,047 | -100.0% | -1.09% | – |
| AXNX | Exit | AXONICS MODULATION TECHNOLOG | $0 | – | -54,089 | -100.0% | -1.46% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -46,166 | -100.0% | -3.44% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -76,268 | -100.0% | -3.44% | – |
| QDEL | Exit | QUIDEL CORP | $0 | – | -30,751 | -100.0% | -3.58% | – |
| OSUR | Exit | ORASURE TECHNOLOGIES INC | $0 | – | -625,109 | -100.0% | -4.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-04-29
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
| IRADIMED CORP | 16 | Q3 2023 | 5.8% |
| XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
| IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
| SURMODICS INC | 14 | Q3 2023 | 4.7% |
| NATERA INC | 13 | Q3 2023 | 3.9% |
| DEXCOM INC | 13 | Q2 2023 | 4.2% |
| NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
| CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
| LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.